In the war against bioterror, genomic companies are becoming more noticeable. Consider: Maxygen has received grants from DARPA for its MolecularBreeding technologies, which promise rapidly to deliver antigens for immunization. The technology also has been designed to generate new vaccines with a broad spectrum of activity against multiple strains of several different pathogens, and deliver aerosol-based preventative and therapeutic agents.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.